Utilization of Percutaneous Needle Biopsy for Breast Diagnosis in a Comprehensive Breast Center: Implications for Development of Quality Indicators.

about

Utilization of Percutaneous Needle Biopsy for Breast Diagnosis in a Comprehensive Breast Center: Implications for Development of Quality Indicators.

Item

http://www.wikidata.org/entity/Q40360190

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Utilization of Percutaneous Ne ...... lopment of Quality Indicators.

@en

type

Item

label

Utilization of Percutaneous Ne ...... lopment of Quality Indicators.

@en

prefLabel

Utilization of Percutaneous Ne ...... lopment of Quality Indicators.

@en

P1476

Utilization of Percutaneous Ne ...... elopment of Quality Indicators

@en

P2093

Lolwah Al-Riyees

http://www.w3.org/2001/XMLSchema#string

Refik Saskin

http://www.w3.org/2001/XMLSchema#string

P2860

Quality assurance initiative at one institution for minimally invasive breast biopsy as the initial diagnostic technique.

Special report: Consensus conference III. Image-detected breast cancer: state-of-the-art diagnosis and treatment.

Systematic review: comparative effectiveness of core-needle and open surgical biopsy to diagnose breast lesions.

Quality indicators in breast cancer care.

Are percutaneous biopsy rates a reasonable quality measure in breast cancer management?

Improving breast cancer care through a regional quality collaborative.

Role of mammography, ultrasound and large core biopsy in the diagnostic evaluation of papillary breast lesions.

Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors.

Preoperative needle biopsy as a potential quality measure in breast cancer surgery.

Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial.

P2888

s00268-015-3293-0

P304

1590-1599

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00268-015-3293-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Claire M B Holloway

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1012051033

http://www.w3.org/2001/XMLSchema#string

P698

26530690

http://www.w3.org/2001/XMLSchema#string